Insights on Discovery
-
Materials Matter: Reframing Raw Material Strategy In Cell And Gene Therapy Development
5/1/2026
Scaling iPSC-based therapies from lab to CGMP manufacturing demands tightly controlled cryopreservation, risk-based QC, and strategic automation to preserve cell viability, consistency, and regulatory readiness.
-
Sensitive Viral Safety Testing For Adventitious Virus Detection
4/20/2026
Discover a modern approach to adventitious virus detection that shows how targeted sequencing can achieve sensitive, comprehensive viral safety testing aligned with ICH MAP, RAP, and HAP expectations.
-
Direct Cell Lysis Enables Rapid And Robust VCN Quantification
4/20/2026
Explore a faster approach to vector copy number measurement that replaces DNA extraction with direct cell lysis and digital PCR, delivering accurate, reproducible results across fresh and frozen samples.
-
Enhanced Lentiviral Vector Characterization Using Digital PCR
4/20/2026
Digital PCR offers a precise, scalable approach to lentiviral vector characterization, enabling reliable genome titer, vector copy number, and RCL detection while reducing variability.
-
Analytical Performance Evaluation Of A Bead-Based Cytokine Assay
4/17/2026
Reliable IFN‑γ measurement is critical for understanding T cell function. See how analytical rigor, from accuracy to matrix effects, supports consistent cytokine quantification across development.
-
ADC Development Grows More Complex — SPR Insights Bring Clarity
4/14/2026
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
What FDA CRLs Reveal About CCIT
4/14/2026
FDA rejection letters show common CCIT gaps — low sensitivity and incomplete validation. Spotting these trends helps teams strengthen integrity testing and avoid approval delays.
-
Evaluating Carryover When Using A TOC Analyzer
4/10/2026
Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.
-
In-Line Monitoring Of Culture Medium Using Live Cell Metabolic Analyzer
4/7/2026
Continuous in-line monitoring of glucose and lactate levels provides highly accurate, real-time data on cellular metabolism without the risks or data gaps associated with manual periodic sampling.
-
Novel Cardiotoxicity Evaluation Method Using iPS-Derived Cardiomyocytes
4/7/2026
Discover how real-time monitoring of glucose and lactate in iPS-derived cardiomyocytes reveals subtle drug-induced metabolic shifts that traditional screening methods often fail to detect.